Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2003

View Archived Issues

BLX-1002: a novel non-PPARgamma agonist, nonadipogenic antidiabetic agent

Beneficial effects reported for satraplatin combined with prednisone in HRPC

Donepezil improves REM sleep alterations in Alzheimer's disease

Lower risk for osteoporotic bone fractures with strontium ranelate in postmenopausal women

Antiobesity agents in early development at Merck KGaA

Effective control of serum glucose and insulin levels with an oral insulin spray in type 1 diabetes

Pfizer claims new KDR/FLK-1 modulators with utility in cancer and other disorders

Novel 5-HT receptor modulators and their use covered by Pharmacia (Pfizer) patent

Dabur scientists design novel antitumor polypeptides

Inhibitors of PDE4 and TNF-alpha production covered in Warner-Lambert patent

AOD-9604 reduces serum fatty acids and body weight in obese patients

Somatostatin receptor ligands and their use in acromegaly and other disorders

Novel rifamycin-drug conjugates in ActivBiotics pipeline

BIM-23190 reduces serum insulin and growth hormone levels in type 2 diabetes

Takeda researchers present new somatostatin receptor ligands in recent patent

Immunogenicity study of StaphVAX gets under way

Disappointing results for memantine/acetylcholinesterase inhibitors in AD study

CuraGen restructures to focus resources on advancing pipeline

AVI-4126 detected in breast and prostate tumors

Positive interim results for Tostrelle in female sexual dysfunction

Genentech and Idec to develop humanized anti-CD20 antibodies

Palonosetron phase III program reports results

Reduction in opportunistic infections in AIDS patients receiving Immunitin

Phase IIb results for Aurograb in MRSA infection

Preliminary findings for Ceplene in stage IV malignant melanoma

Insmed's rhIGF-I/rhIGFBP-3 granted orphan drug designation in Europe

Steroidal estrogen agonist from J&J characterized in vitro and in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...